Medical Research News and Interviews on MedicalResearch.com (blog) Dr. Hodson: Type 2 diabetes represents a huge socioeconomic challenge. As well as causing significant morbidity due to chronically elevated glucose levels, this disease is also a drain on healthcare budgets (~$20billion in the UK per year). While ...
Clinical Advisor The biguanide metformin, widely used in the treatment of type 2 diabetes, was associated with a 55% increased risk of low thyroid-stimulating hormone (TSH) levels in patients with hypothyroidism when compared with sulfonylurea use. The research ...
The Pharmaceutical Journal Joanna is a freelance medical writer with a BSc (Hons) in Medical Science & Pharmacology and 15 years' experience working in the field of medical communications. Journalistic work includes clinical research summaries, interviews, feature articles and ...
Monthly Prescribing Reference A review in the journal Clinical Diabetes evaluates the safety and efficacy of saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, as an add-on therapy to metformin, sulfonylurea (SU), a thiazolidinedione (TZD), or insulin (with or without ...
Medscape The investigators initially looked at a total 74,300 patients who were at least 40 years of age and had begun receiving either metformin or sulfonylurea monotherapy between 1988 and 2012. Of those, 5689 had treated hypothyroidism and 59,937 were ... and more »
The Pharmaceutical Journal Joanna is a freelance medical writer with a BSc (Hons) in Medical Science & Pharmacology and 15 years' experience working in the field of medical communications. Journalistic work includes clinical research summaries, interviews, feature articles and ...
Delhi Daily News The coauthors studied that sulfonylurea compounds are extensively used for treating type 2 diabetes mellitus (T2DM), which through their actions on AT...
FarmersWeekly With wheat drilling almost finished, many growers will face an anxious wait to see if their pre-emergence herbicides have done the job and turn their attention to the next line of attack focused on troublesome weeds such as blackgrass. Adam Clarke reports.
Everyday Health Sulfonylurea stimulates the release of insulin from the pancreas. While the medication does work quickly, it may cause hypoglycemia, weight gain, nausea, and skin rashes. TZD, or Thiazolidinedione, helps improve the body's sensitivity to insulin and ... and more »
Photonics.com The researchers created JB253 by adapting the existing sulfonylurea family of drugs, which, via ATP-sensitive potassium channels in the pancreas, can “boost insulin release from the pancreatic beta cell mass to restore glucose homeostasis” in diabetes ...
